NL192109B - Kristallijne iminiumzouten, werkwijze ter bereiding daarvan, cardiotonische preparaten die deze zouten bevatten, alsmede hun toepassing ter bereiding van bypiridinonderivaten. - Google Patents

Kristallijne iminiumzouten, werkwijze ter bereiding daarvan, cardiotonische preparaten die deze zouten bevatten, alsmede hun toepassing ter bereiding van bypiridinonderivaten.

Info

Publication number
NL192109B
NL192109B NL8100922A NL8100922A NL192109B NL 192109 B NL192109 B NL 192109B NL 8100922 A NL8100922 A NL 8100922A NL 8100922 A NL8100922 A NL 8100922A NL 192109 B NL192109 B NL 192109B
Authority
NL
Netherlands
Prior art keywords
preparation
salts
bypiridinone
crystalline
derivatives
Prior art date
Application number
NL8100922A
Other languages
English (en)
Other versions
NL8100922A (nl
NL192109C (nl
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NL8100922A publication Critical patent/NL8100922A/nl
Publication of NL192109B publication Critical patent/NL192109B/nl
Application granted granted Critical
Publication of NL192109C publication Critical patent/NL192109C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8100922A 1980-02-26 1981-02-25 Kristallijne iminiumzouten, werkwijze ter bereiding daarvan, cardiotonische preparaten die deze zouten bevatten, alsmede hun toepassing ter bereiding van bypiridinonderivaten. NL192109C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic
US12480880 1980-02-26

Publications (3)

Publication Number Publication Date
NL8100922A NL8100922A (nl) 1981-09-16
NL192109B true NL192109B (nl) 1996-10-01
NL192109C NL192109C (nl) 1997-02-04

Family

ID=22416880

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100922A NL192109C (nl) 1980-02-26 1981-02-25 Kristallijne iminiumzouten, werkwijze ter bereiding daarvan, cardiotonische preparaten die deze zouten bevatten, alsmede hun toepassing ter bereiding van bypiridinonderivaten.

Country Status (28)

Country Link
US (1) US4264609A (nl)
JP (1) JPS56128758A (nl)
KR (2) KR840002067B1 (nl)
AR (1) AR230630A1 (nl)
AT (2) AT380237B (nl)
AU (1) AU541644B2 (nl)
BE (1) BE887663A (nl)
CA (1) CA1128523A (nl)
CH (1) CH647509A5 (nl)
DE (1) DE3107306A1 (nl)
DK (1) DK171253B1 (nl)
ES (1) ES499776A1 (nl)
FI (1) FI76787C (nl)
FR (1) FR2476646A1 (nl)
GB (1) GB2070600B (nl)
HK (1) HK71789A (nl)
IE (1) IE51696B1 (nl)
IL (1) IL62161A (nl)
IT (1) IT1210992B (nl)
LU (1) LU83169A1 (nl)
MX (1) MX6908E (nl)
NL (1) NL192109C (nl)
NO (1) NO156689C (nl)
NZ (1) NZ196282A (nl)
PH (2) PH19904A (nl)
PT (1) PT72573B (nl)
SE (2) SE437514B (nl)
ZA (1) ZA811124B (nl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024B1 (de) 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
AT380237B (de) 1986-04-25
NL8100922A (nl) 1981-09-16
SE437514B (sv) 1985-03-04
FR2476646A1 (fr) 1981-08-28
MX6908E (es) 1986-11-07
DE3107306A1 (de) 1981-12-17
IE810397L (en) 1981-08-26
FI76787B (fi) 1988-08-31
AU6748781A (en) 1981-09-03
NO156689B (no) 1987-07-27
DE3107306C2 (nl) 1990-11-29
SE8402727D0 (sv) 1984-05-21
ZA811124B (en) 1982-03-31
AR230630A1 (es) 1984-05-31
IL62161A0 (en) 1981-03-31
BE887663A (fr) 1981-08-25
NO810639L (no) 1981-08-27
KR840002066B1 (ko) 1984-11-09
CH647509A5 (fr) 1985-01-31
US4264609A (en) 1981-04-28
AT380236B (de) 1986-04-25
ES499776A1 (es) 1984-06-16
NO156689C (no) 1987-11-04
FI810582L (fi) 1981-08-27
SE8101205L (sv) 1981-08-27
DK83981A (da) 1981-08-27
NZ196282A (en) 1983-12-16
IL62161A (en) 1984-06-29
KR830005143A (ko) 1983-08-03
IE51696B1 (en) 1987-02-18
IT8119952A0 (it) 1981-02-24
PH19904A (en) 1986-08-13
GB2070600B (en) 1984-07-11
SE452764B (sv) 1987-12-14
JPH0141626B2 (nl) 1989-09-06
ATA88581A (de) 1985-09-15
KR840002067B1 (ko) 1984-11-09
HK71789A (en) 1989-09-14
PT72573B (en) 1982-02-12
LU83169A1 (fr) 1981-09-11
CA1128523A (en) 1982-07-27
DK171253B1 (da) 1996-08-12
FI76787C (fi) 1988-12-12
GB2070600A (en) 1981-09-09
ATA305683A (de) 1985-09-15
NL192109C (nl) 1997-02-04
PT72573A (pt) 1981-03-01
FR2476646B1 (nl) 1984-08-17
JPS56128758A (en) 1981-10-08
IT1210992B (it) 1989-09-29
AU541644B2 (en) 1985-01-17
SE8402727L (sv) 1984-05-21
PH17145A (en) 1984-06-04

Similar Documents

Publication Publication Date Title
NL930045I2 (nl) 7-Acylamino-3-vinylcefalosporanzuurderivaten, werkwijzen ter bereiding daarvan, farmaceutische preparaten die deze bevatten, hun uitgangsverbindingen en de bereiding daarvan.
CA971969A (en) Process for preparing hydantoin derivatives and herbicidal composition containing the same
NL7702345A (nl) Werkwijze ter bereiding van titaniumverbindingen.
NL7708658A (nl) Werkwijze ter bereiding van azolylcarbonzuurderi- vaten en werkwijze ter bereiding van fungiciden daarmee.
NL7611706A (nl) Werkwijze ter bereiding van nieuwe cefalospori- nederivaten en de toepassing ervan in farma- ceutische preparaten.
NL8002147A (nl) Penem-3-carbonzuurderivaten hun bereiding en gebruik.
NL7709055A (nl) Werkwijze ter bereiding van 3-chloorcefalosporine- derivaten.
NL7812600A (nl) Werkwijze ter bereiding van guanidinederivaten.
NL7415589A (nl) Gesubstitueerde (alpha)-aminooxycarbonzuurhydrazide derivaten en zuuradditiezouten ervan en werk- wijzen voor hun bereiding en toepassing.
NL7800744A (nl) Nieuwe imidazochinolinen en hun zouten, werk- wijze ter bereiding van deze verbindingen en farmaceutische samenstellingen.
NL7707308A (nl) Werkwijze ter bereiding van 2-broom-6-fluor- -n-2-imidazolidinylideenbenzamide en de zuur- additiezouten daarvan en van preparaten, die deze verbindingen bevatten.
NL7608297A (nl) Werkwijze voor de bereiding en toepassing van derivaten van gesubstitueerde n-alkylimidazolen.
NL7714372A (nl) Fosfoncarbonzuurderivaten, alsmede werkwijze ter bereiding van dergelijke verbindingen.
NL187533B (nl) Werkwijze ter bereiding van 6alfa-halogeenpregnaanderivaten, alsmede tussenprodukten van deze werkwijze.
NL177110C (nl) Werkwijze voor het bereiden van 1-amino-2-propanolderivaten, en hun bevattende preparaten voor het bestrijden van micro-organismen.
NL7701782A (nl) Bereidingswijze van o-aminofenylketonderivaten.
NL7711371A (nl) Werkwijze ter bereiding van (alpha)-thio-alkaanzuur- derivaten.
NL7611707A (nl) Werkwijze ter bereiding van nieuwe cefalospori- nederivaten en de toepassing ervan in farma- ceutische preparaten.
NL7707713A (nl) Werkwijze ter bereiding van nieuwe amino-alko- xybenzofuranverbindingen, en hun toepassing in geneesmiddelen.
NL7801057A (nl) Gamma-aryl-gamma-oxo-isovaleriaanzuurderivaten en werkwijze ter bereiding van deze verbindingen.
NL192109B (nl) Kristallijne iminiumzouten, werkwijze ter bereiding daarvan, cardiotonische preparaten die deze zouten bevatten, alsmede hun toepassing ter bereiding van bypiridinonderivaten.
NL7714205A (nl) Werkwijze ter bereiding van 5-fluoruracilderi- vaten en farmaceutische preparaten die deze derivaten bevatten.
NL187396C (nl) Werkwijze ter bereiding van farmaceutische preparaten die 1-sulfonyl-2-aminobenzimidazoolderivaten bevatten, werkwijze ter bereiding van 1-sulfonyl-2-aminobenzimidazoolderivaten, alsmede gevormde farmaceutische preparaten.
NL7710325A (nl) Werkwijze ter bereiding van nieuwe chinolinede- rivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL179535C (nl) Werkwijze ter bereiding van fungicide preparaten op basis van furancarboxamidederivaten, het gevormde fungicide preparaat, alsmede werkwijze ter bereiding van deze furancarboxamidederivaten.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
SNR Assignments of patents or rights arising from examined patent applications

Owner name: SANOFI PHARMACEUTICALS, INC.

TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: STERLING WINTHROP INC.

TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: SANOFI-SYNTHELABO INC.

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010225